Trial Profile
A Randomized, Phase 3, Controlled, Double-Blind, Parallel-Group, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Combination With Methotrexate (MTX) Compared to MTX Alone, in Methotrexate-Naive Patients With Active Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Methotrexate (Primary) ; Methotrexate (Primary) ; Rituximab (Primary) ; Folic acid; Methylprednisolone
- Indications Rheumatoid arthritis
- Focus Registrational; Therapeutic Use
- Acronyms IMAGE
- Sponsors Genentech; Roche
- 10 Nov 2012 Planned number of patients changed from 750 to 853.
- 09 Aug 2011 Status changed from active, no longer recruiting to completed.
- 19 Jun 2010 Two-year results were presented at the 11th Annual Congress of the European League Against Rheumatism.